Truepoint, Inc. Abbott Laboratories Transaction History

Truepoint, Inc.

$3.66 Billion
Q4 2024

A detailed history of Truepoint, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Truepoint, Inc. holds 2,339 shares of ABT stock, worth $296,374. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,339

Previous 2,169 7.84%

Holding current value

$296,374

Previous $247,000 6.88%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$111.93 - $119.39 $19,028 - $20,296	170 Added 7.84%	2,339 $264,000
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $49,734 - $58,710	-497 Reduced 18.64%	2,169 $247,000
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $11,986 - $13,380	-119 Reduced 4.27%	2,666 $277,000
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $503,572 - $556,174	-4,598 Reduced 62.28%	2,785 $316,000
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $296,905 - $363,436	3,292 Added 80.47%	7,383 $812,000
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $15,475 - $18,568	162 Added 4.12%	4,091 $396,000
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $154,193 - $171,803	1,530 Added 63.78%	3,929 $428,000
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $55,403 - $65,213	572 Added 31.31%	2,399 $242,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $30,894 - $36,244	-325 Reduced 15.1%	1,827 $200,000
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $219,654 - $265,492	2,152 New	2,152 $234,000
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $171,258 - $208,838	-1,502 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $173,526 - $212,472	1,502 New	1,502 $211,000
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $189,140 - $214,268	-2,885 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $175,436 - $211,643	2,885 New	2,885 $212,000

Others Institutions Holding ABT

# of Institutions

3,376

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $222B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truepoint, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Truepoint, Inc. with notifications on news.

Account